208 related articles for article (PubMed ID: 35843927)
21. Hyperandrogenism due to ovarian Leydig cell tumour presenting with polycythaemia.
Demir AY; Blok BB; Brinkhuis EA; Oldenburg-Ligtenberg CP
BMJ Case Rep; 2022 Jul; 15(7):. PubMed ID: 35840164
[TBL] [Abstract][Full Text] [Related]
22. [The ovarian origin of hiperandrogenism in the postmenopausal woman the adrenal adenoma--a case report].
Mrozińska S; Kiałka M; Doroszewska K; Milewicz T; Jach R
Przegl Lek; 2015; 72(7):387-90. PubMed ID: 26817354
[TBL] [Abstract][Full Text] [Related]
23. Androgens in Menopausal Women: Not Only Polycystic Ovary Syndrome.
Kostakis EK; Gkioni LN; Macut D; Mastorakos G
Front Horm Res; 2019; 53():135-161. PubMed ID: 31499509
[TBL] [Abstract][Full Text] [Related]
24. [A case of postmenopausal hyperandrogenism caused by a lipid cell tumor].
Witek A; Skałba P; Chełmicki Z; Pajak J
Wiad Lek; 2002; 55(1-2):125-30. PubMed ID: 12043310
[TBL] [Abstract][Full Text] [Related]
25. Ovarian steroid cell tumor and a contralateral ovarian thecoma in a postmenopausal woman with severe hyperandrogenism.
Cserepes E; Szücs N; Patkós P; Csapó Z; Molnár F; Tóth M; Dabasi G; Esik O; Rácz K
Gynecol Endocrinol; 2002 Jun; 16(3):213-6. PubMed ID: 12192893
[TBL] [Abstract][Full Text] [Related]
26. Bilateral Leydig Cell Hyperplasia: A Rare Cause of Postmenopausal Hirsutism.
Pathmanathan S; De Silva SDN; Sumanatilleke M; Lokuhetty D; Ranathunga UVV
Case Rep Endocrinol; 2022; 2022():8804856. PubMed ID: 35190778
[TBL] [Abstract][Full Text] [Related]
27. Clinical Case Seminar: Postmenopausal androgen excess-challenges in diagnostic work-up and management of ovarian thecosis.
Mamoojee Y; Ganguri M; Taylor N; Quinton R
Clin Endocrinol (Oxf); 2018 Jan; 88(1):13-20. PubMed ID: 28980338
[TBL] [Abstract][Full Text] [Related]
28. Postmenopausal mild hirsutism and hyperandrogenemia due to granulosa cell tumor of the ovary: a case report.
Adefris M; Fekadu E
J Med Case Rep; 2017 Aug; 11(1):242. PubMed ID: 28851436
[TBL] [Abstract][Full Text] [Related]
29. Use of a long-acting gonadotrophin-releasing hormone analogue in a postmenopausal woman with hyperandrogenism due to a hilus cell tumour.
Picón MJ; Lara JI; Sarasa JL; Recasens JD; Clouet R; Gonzalo MA; Rovira A
Eur J Endocrinol; 2000 Jun; 142(6):619. PubMed ID: 10822225
[TBL] [Abstract][Full Text] [Related]
30. Postmenopausal hyperandrogenism: the under-recognized value of inhibins.
Shearer JL; Salmons N; Murphy DJ; Gama R
Ann Clin Biochem; 2017 Jan; 54(1):174-177. PubMed ID: 27278937
[TBL] [Abstract][Full Text] [Related]
31. Postmenopausal hyperandrogenism caused by a benign cystic teratoma: a case report.
Wu DH; McMurtrie DG; Hirsch SD; Johnston CM
J Reprod Med; 2008 Feb; 53(2):141-4. PubMed ID: 18357809
[TBL] [Abstract][Full Text] [Related]
32. Dexamethasone suppression test versus selective ovarian and adrenal vein catheterization in identifying virilizing tumors in postmenopausal hyperandrogenism - a systematic review and meta-analysis.
Tng EL; Tan JM
Gynecol Endocrinol; 2021 Jul; 37(7):600-608. PubMed ID: 33660585
[TBL] [Abstract][Full Text] [Related]
33. Exploring the unusual: a testosterone-secreting ovarian tumor.
Kaur H; Singh N; Bharti S; Kaur G
Autops Case Rep; 2024; 14():e2024478. PubMed ID: 38487035
[TBL] [Abstract][Full Text] [Related]
34. Postmenopausal androgen-secreting ovarian tumors: challenging differential diagnosis in two cases.
Arteaga E; Martinez A; Jaramilo J; Villaseca P; Cuello M; Valenzuela P; Gejman R; Blumel JE
Climacteric; 2019 Aug; 22(4):324-328. PubMed ID: 30623686
[TBL] [Abstract][Full Text] [Related]
35. Ovarian suppression with triptorelin and adrenal stimulation with adrenocorticotropin in functional hyperadrogenism: role of adrenal and ovarian cytochrome P450c17 alpha.
Escobar-Morreale H; Pazos F; Potau N; García-Robles R; Sancho JM; Varela C
Fertil Steril; 1994 Sep; 62(3):521-30. PubMed ID: 8062947
[TBL] [Abstract][Full Text] [Related]
36. Diagnosis of hyperandrogenism: biochemical criteria.
Stanczyk FZ
Best Pract Res Clin Endocrinol Metab; 2006 Jun; 20(2):177-91. PubMed ID: 16772150
[TBL] [Abstract][Full Text] [Related]
37. Sertoli-Leydig cell ovarian tumour: a rare cause of virilisation and androgenic alopecia.
Mudraje S; Shetty S; Guruvare S; Kudva R
BMJ Case Rep; 2022 Aug; 15(8):. PubMed ID: 36007974
[TBL] [Abstract][Full Text] [Related]
38. [Androgenic alopecia revealing an androgen secreting ovarian tumor].
Roux-Guinot S; Gorin I; Vadrot D; Djid R; Bethoux JP; Escande JP
Ann Dermatol Venereol; 2001 Nov; 128(11):1241-4. PubMed ID: 11908171
[TBL] [Abstract][Full Text] [Related]
39. Leydig cell tumour and mature ovarian teratoma: rare androgen-secreting ovarian tumours in postmenopausal women.
Palha A; Cortez L; Tavares AP; Agapito A
BMJ Case Rep; 2016 Nov; 2016():. PubMed ID: 27803082
[TBL] [Abstract][Full Text] [Related]
40. Coincidental diagnosis of an occult hilar steroid cell tumor of the ovary and a cortisol-secreting adrenal adenoma in a 49-year-old woman with severe hyperandrogenism.
Gorgojo JJ; Almodóvar F; López E; Vicente del Cerro J; Tejerina E; Donnay S
Fertil Steril; 2003 Dec; 80(6):1504-7. PubMed ID: 14667891
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]